B7-h3 ligand expression by primary breast cancer and associated with regional nodal metastasis.
about
Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?T cell coinhibition and immunotherapy in human breast cancerB7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcomeB7-H3 expression in breast cancer and upregulation of VEGF through gene silenceExpression of B7-H3, a potential factor of tumor immune evasion in combination with the number of regulatory T cells, affects against recurrence-free survival in breast cancer patientsB7-H3 is overexpressed in patients suffering osteosarcoma and associated with tumor aggressiveness and metastasis.Characterization of a soluble B7-H3 (sB7-H3) spliced from the intron and analysis of sB7-H3 in the sera of patients with hepatocellular carcinoma.Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.A novel subset of B7-H3+CD14+HLA-DR-/low myeloid-derived suppressor cells are associated with progression of human NSCLC.B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation.A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patientsBreast Cancer Detection by B7-H3-Targeted Ultrasound Molecular ImagingB7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells.Glycoprotein B7-H3 overexpression and aberrant glycosylation in oral cancer and immune response.Silencing of B7-H3 increases gemcitabine sensitivity by promoting apoptosis in pancreatic carcinoma.Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitorsImmunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1αB7-H3 protein expression in a murine model of osteosarcoma.Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1.B7 family checkpoint regulators in immune regulation and disease.B7-H3-mediated tumor immunology: Friend or foe?The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: What lies beneath the tip of the iceberg, PD-L1.Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature.Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma.Blocking mtDNA replication upregulates the expression of stemness-related genes in prostate cancer cell lines.B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence.B7-H3 role in the immune landscape of cancer.B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes.Artemether Regulates Chemosensitivity to Doxorubicin via Regulation of B7-H3 in Human Neuroblastoma CellsLymphatics, lymph nodes and the immune system: barriers and gateways for cancer spread.miR-708-5p: a microRNA with emerging roles in cancer.Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis.B7H3 As a Promoter of Metastasis and Promising Therapeutic Target
P2860
Q26740601-308A7954-BDA8-47C7-9C44-9865FF19A5E6Q33936154-75D63CDF-E3B6-4539-BDA7-63217C393AE1Q34105913-DECDDC9E-3A9A-458C-8F58-A4ECE328AD92Q34446315-05CC59A1-1779-4556-B25A-9CEFA6F137D5Q34538321-D7C534B5-CB65-424E-8BDD-DD0768F2E268Q34935785-B2D25F64-8230-47B0-877C-2D1C7AA59086Q35032331-456D0BE5-EAF2-4D5B-9576-5DA922E52A03Q35104159-0F4CA448-0E89-49A9-8ED9-648C0D5CBA77Q35506243-7ADF1E97-79B8-41B7-96F1-8C57EBA62676Q35660790-18CD01EC-EA14-435A-8B2C-6DFC7E19463FQ35740150-EE92363B-748D-4B25-AB56-C9A276B26EFFQ35751840-2FC6944A-D596-49F2-9DBE-6E465F5F9AEBQ35867721-F1ABEE78-89AB-4B08-BA59-8810757FCEC4Q36207260-C233C2E1-A74C-4F2E-8802-BFE9C18AA59DQ36621122-0768A477-D8DB-4A8A-8579-869C567ED1EAQ36916365-DE37408A-F1CF-456A-9E16-A48F3A04ED4AQ36921665-E08DF613-8A92-46E9-B057-54112A63C25FQ37001496-7C43E6A7-84AF-46C6-8954-E8E17309133CQ37158481-C715E2C9-E625-4837-A417-00F576EE3143Q38129635-1A10BE3C-2E5B-4F06-BDD1-8EFDFC640E95Q38135281-519B03A3-7F4F-4554-AC38-6187CD867140Q38684886-1E1C5C19-EEBC-40C3-9C37-68F57E4C0CF8Q38708078-701A2C2C-7B8D-4CAF-ACE9-8AD9E55EE140Q38847201-2EAE071A-9ECA-42B7-80B1-81296C26328CQ39157835-89634854-D0DA-41F8-AB2E-37BC6B4AF57FQ39325949-05FD0926-6A32-46AB-880B-B8C275F75890Q39427326-8671DA4B-38A1-4BDD-8A95-C3448FB3F39CQ39524901-068E270C-B2DD-4034-84DD-158888B22B5FQ41248541-75A1440C-6D80-4D35-99E4-DACECE9EA688Q41600452-7D861E00-F388-4B1B-BC1B-F0264240ADDEQ42378530-F69E7655-35E4-4A93-B890-5A2FF43358CAQ47150218-7CE36804-CA15-41F0-9E7F-D7E63E01AD45Q57176931-770807CD-6DFE-496C-B08F-CD0AD2B1C2EC
P2860
B7-h3 ligand expression by primary breast cancer and associated with regional nodal metastasis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
B7-h3 ligand expression by pri ...... ith regional nodal metastasis.
@en
type
label
B7-h3 ligand expression by pri ...... ith regional nodal metastasis.
@en
prefLabel
B7-h3 ligand expression by pri ...... ith regional nodal metastasis.
@en
P2093
P1433
P1476
B7-h3 ligand expression by pri ...... with regional nodal metastasis
@en
P2093
Alice Chung
Armando E Giuliano
Linhda Nguyen
Norihiko Narita
Ryuichi Mizuno
Takaaki Arigami
P304
P356
10.1097/SLA.0B013E3181F1939D
P407
P50
P577
2010-12-01T00:00:00Z